These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

598 related articles for article (PubMed ID: 22617140)

  • 41. The role of the Staphylococcal VraTSR regulatory system on vancomycin resistance and vanA operon expression in vancomycin-resistant Staphylococcus aureus.
    Qureshi NK; Yin S; Boyle-Vavra S
    PLoS One; 2014; 9(1):e85873. PubMed ID: 24454941
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antimicrobial Resistance and Molecular Epidemiology of Staphylococcus aureus Causing Bloodstream Infections at Ruijin Hospital in Shanghai from 2013 to 2018.
    Gu F; He W; Xiao S; Wang S; Li X; Zeng Q; Ni Y; Han L
    Sci Rep; 2020 Apr; 10(1):6019. PubMed ID: 32265473
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Investigation of SCCmec types and Panton-Valentine leukocidin in community-acquired and nosocomial Staphylococcus aureus strains: comparing skin and soft tissue infections to the other infections].
    Gülmez D; Sancak B; Ercis S; Karakaya J; Hasçelik G
    Mikrobiyol Bul; 2012 Jul; 46(3):341-51. PubMed ID: 22951646
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antibiotic susceptibility and genomic variations in Staphylococcus aureus associated with Skin and Soft Tissue Infection (SSTI) disease groups.
    Changchien CH; Chen SW; Chen YY; Chu C
    BMC Infect Dis; 2016 Jun; 16():276. PubMed ID: 27287530
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vitro activity of oritavancin against community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA), vancomycin-intermediate S. aureus (VISA), vancomycin-resistant S. aureus (VRSA) and daptomycin-non-susceptible S. aureus (DNSSA).
    Saravolatz LD; Pawlak J; Johnson LB
    Int J Antimicrob Agents; 2010 Jul; 36(1):69-72. PubMed ID: 20413274
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Staphylococcus aureus resistant to vancomycin--United States, 2002.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2002 Jul; 51(26):565-7. PubMed ID: 12139181
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hospital Dissemination of
    Wang M; Zheng Y; Mediavilla JR; Chen L; Kreiswirth BN; Song Y; Yang R; Du H
    Front Cell Infect Microbiol; 2017; 7():101. PubMed ID: 28409124
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Acquisition and cross-transmission of Staphylococcus aureus in European intensive care units.
    Bloemendaal AL; Fluit AC; Jansen WM; Vriens MR; Ferry T; Argaud L; Amorim JM; Resende AC; Pascual A; López-Cerero L; Stefani S; Castiglione G; Evangelopoulou P; Tsiplakou S; Rinkes IH; Verhoef J
    Infect Control Hosp Epidemiol; 2009 Feb; 30(2):117-24. PubMed ID: 19133819
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Vancomycin-resistant Staphylococcus aureus in the United States, 2002-2006.
    Sievert DM; Rudrik JT; Patel JB; McDonald LC; Wilkins MJ; Hageman JC
    Clin Infect Dis; 2008 Mar; 46(5):668-74. PubMed ID: 18257700
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Genomic epidemiology of methicillin-resistant and -susceptible Staphylococcus aureus from bloodstream infections.
    Smith JT; Eckhardt EM; Hansel NB; Eliato TR; Martin IW; Andam CP
    BMC Infect Dis; 2021 Jun; 21(1):589. PubMed ID: 34154550
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Molecular epidemiology of methicillin-resistant and methicillin-susceptible Staphylococcus aureus isolated from the eye.
    Hesje CK; Sanfilippo CM; Haas W; Morris TW
    Curr Eye Res; 2011 Feb; 36(2):94-102. PubMed ID: 21158584
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ceftaroline pharmacodynamic activity versus community-associated and healthcare-associated methicillin-resistant Staphylococcus aureus, heteroresistant vancomycin-intermediate S. aureus, vancomycin-intermediate S. aureus and vancomycin-resistant S. aureus using an in vitro model.
    Zhanel GG; Rossnagel E; Nichol K; Cox L; Karlowsky JA; Zelenitsky S; Noreddin AM; Hoban DJ
    J Antimicrob Chemother; 2011 Jun; 66(6):1301-5. PubMed ID: 21429940
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Vancomycin intermediate and resistant Staphylococcus aureus. What the nephrologist needs to know.
    McDonald LC; Hageman JC
    Nephrol News Issues; 2004 Oct; 18(11):63-4, 66-7, 71-2 passim. PubMed ID: 15551615
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin.
    Hiramatsu K; Aritaka N; Hanaki H; Kawasaki S; Hosoda Y; Hori S; Fukuchi Y; Kobayashi I
    Lancet; 1997 Dec; 350(9092):1670-3. PubMed ID: 9400512
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The emergence of vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus.
    Appelbaum PC
    Clin Microbiol Infect; 2006 Mar; 12 Suppl 1():16-23. PubMed ID: 16445720
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Insights into the molecular basis of reduced vancomycin susceptibility among three prominent
    Malachowa N; Sturdevant DE; Porter AR; Martin G; Martens C; Nair V; Hansen B; Ricklefs S; Jenkins SG; Chen L; Kreiswirth BN; DeLeo FR
    Microbiol Spectr; 2024 Aug; 12(8):e0048624. PubMed ID: 38916317
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Changes in the epidemiology of methicillin-resistant Staphylococcus aureus in a Greek tertiary care hospital, over an 8-year-period.
    Pantazatou A; Papaparaskevas J; Stefanou I; Papanicolas J; Demertzi E; Avlamis A
    Int J Antimicrob Agents; 2003 Jun; 21(6):542-6. PubMed ID: 12791467
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dissemination of antibiotic resistance in methicillin-resistant Staphylococcus aureus and vancomycin-resistant S aureus strains isolated from hospital effluents.
    Mandal SM; Ghosh AK; Pati BR
    Am J Infect Control; 2015 Dec; 43(12):e87-8. PubMed ID: 26422180
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Convergent adaptation in the dominant global hospital clone ST239 of methicillin-resistant Staphylococcus aureus.
    Baines SL; Holt KE; Schultz MB; Seemann T; Howden BO; Jensen SO; van Hal SJ; Coombs GW; Firth N; Powell DR; Stinear TP; Howden BP
    mBio; 2015 Mar; 6(2):e00080. PubMed ID: 25736880
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Multidrug and vancomycin resistance among clinical isolates of
    Olufunmiso O; Tolulope I; Roger C
    Afr Health Sci; 2017 Sep; 17(3):797-807. PubMed ID: 29085408
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.